Korea, Republic of (KR)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Fine tuning of the magnetic properties in Mn3-xCoxGa Heusler films near the critical regime (2021) Lee K, Yoo W, Nguyen QAT, Bang HW, Kim H, Klaeui M, Rhim SH, Jung MH Journal article Seismic Anisotropy in Subduction Zones: Evaluating the Role of Chloritoid (2021) Lee J, Mookherjee M, Kim T, Jung H, Klemd R Journal article Orbital Rashba effect in a surface-oxidized Cu film (2021) Go D, Jo D, Gao T, Ando K, Bluegel S, Lee HW, Mokrousov Y Journal article Cygnus X-1 contains a 21-solar mass black hole-Implications for massive star winds (2021) Miller-Jones JC, Bahramian A, Orosz JA, Mande I, Gou L, Maccarone TJ, Neijsse CJ, et al. Journal article Radiological and Clinical Value of 7T MRI for Evaluating 3T-Visible Lesions in Pharmacoresistant Focal Epilepsies (2021) Wang ZI, Oh SH, Lowe M, Larvie M, Ruggieri P, Hill V, Statsevych V, et al. Journal article Reactive astrocyte nomenclature, definitions, and future directions (2021) Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhäuser C, et al. Journal article, Review article Addressing Environmental Challenges of Porphyrin Mixtures Obtained from Statistical Syntheses (2021) Hölzel H, Muth M, Lungerich D, Jux N Journal article Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women (2021) Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, Pooley KA, et al. Journal article Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021) O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. Conference contribution Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial (2021) Hurvitz SA, Fresco R, Afenjar K, Stroyakovskiy D, Huang CS, Wildiers H, Jung KH, et al. Conference contribution